Itraconazole and HIV protease inhibitors: an important interaction

被引：15

作者：

MacKenzie-Wood, AR

Whitfeld, MJ

Ray, JE

机构：

[1] Skin & Canc Fdn Australia, Darlinghurst, NSW 2010, Australia

[2] St Vincents Hosp, Dept Dermatol, Sydney, NSW 2010, Australia

[3] St Vincents Hosp, Dept Pharmacol, Sydney, NSW 2010, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 1999年 / 170卷 / 01期

关键词：

D O I：

10.5694/j.1326-5377.1999.tb126872.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：46 / 47

页数：2

共 6 条

[1]

*AD INT LIM, 1994, ITR MON

[2] Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].

Barry, M ;

Gibbons, S ;

Back, D ;

Mulcahy, F .

CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209

[3] ITRACONAZOLE THERAPY FOR HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED EOSINOPHILIC FOLLICULITIS [J].

BERGER, TG ;

HEON, V ;

SCHULZE, K ;

CONANT, MA .

ARCHIVES OF DERMATOLOGY, 1995, 131 (03) :358-360

[4] PHARMACOKINETICS OF ITRACONAZOLE FOLLOWING ORAL-ADMINISTRATION TO NORMAL VOLUNTEERS [J].

HARDIN, TC ;

GRAYBILL, JR ;

FETCHICK, R ;

WOESTENBORGHS, R ;

RINALDI, MG ;

KUHN, JG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (09) :1310-1313

[5]

*JANSS CIL, 1998, SPOR ITRAC PROD INF

[6]

*SYDN MERCK SHARP, 1997, CRIX IND SULF PROD I

← 1 →